Table 1.
Baseline demographic and medical characteristics
| Variable | Overall | EX | UC | P |
|---|---|---|---|---|
| Age (years; N = 14) | 58.8 (12.9) | 64.2 (12.9) | 55.8 (12.6) | .258 |
| Sex (N = 14) | ||||
| Male | 10 | 4 | 6 | .597 |
| Female | 4 | 1 | 3 | |
| Race (N = 14) | ||||
| Caucasian | 11 | 4 | 7 | .923 |
| African American | 3 | 1 | 2 | |
| Education (N = 10) | ||||
| High school or less | 7 | 3 | 4 | .490 |
| Some post secondary school | 3 | 2 | 1 | |
| Body mass index (kg/m2) (N = 14) | 31.5 (7.4) | 29.7(4.3) | 33.4 (9.8) | .462 |
| Smoking status (N = 14) | ||||
| Never smoked | 2 | 1 | 1 | .375 |
| Ex-smoker | 8 | 4 | 4 | |
| Current smoker | 2 | 0 | 2 | |
| Quit during treatment | 2 | 0 | 2 | |
| Exercise at baseline (N = 11) | ||||
| Exerciser | 2 | 0 | 2 | .114 |
| Non-exerciser | 9 | 5 | 4 | |
| MV exercise minutesa | 114.2 (232.1) | 8 (11.0) | 220.4 (304.9) | .158 |
| Moderate exercise minutesb | 47.3 (79.1) | 8 (11.0) | 80 (98.0) | .140 |
| Vigorous exercise minutesc | 6.4 (18.0) | 0 (0) | 11.7 (24.0) | .310 |
| Number of comorbidities (N = 14) | 1.7 (1.1) | 2.2 (0.8) | 1.2 (1.1) | .143 |
| Type of lung cancer (N = 14) | ||||
| Adenocarcinoma | 5 | 1 | 4 | |
| Squamous | 6 | 4 | 2 | |
| Large cell | 1 | 0 | 1 | |
| Small Cell | 1 | 0 | 1 | |
| NSCLC: Poorly differentiated | 1 | 0 | 1 | |
| Stage (N = 14) | ||||
| I | 1 | 0 | 1 | |
| IIB | 2 | 1 | 1 | |
| IIIA | 8 | 2 | 6 | |
| IIIB | 2 | 2 | 0 | |
| IV | 1 | 0 | 1 | |
| Chemotherapy (N = 14) | ||||
| Cisplatin/Irinotecan | 7 | 2 | 5 | |
| Cisplatin/Pemetrexed | 2 | 0 | 2 | |
| Carboplatin/Irinotecan | 2 | 1 | 1 | |
| Paclitaxel/Bevacizum | 1 | 1 | 0 | |
| Carboplatin/Pemetrexed | 1 | 0 | 1 | |
| Taxol/Irinotecan | 1 | 1 | 0 | |
| Radiation Therapy (N = 14) | ||||
| None | 1 | 1 | 0 | |
| 50.4 Gy | 1 | 0 | 1 | |
| 60 Gy | 4 | 1 | 3 | |
| 66 Gy | 7 | 3 | 4 | |
| PCId | 1 | 0 | 1 | |
| Surgery (N = 14) | ||||
| Inoperable | 5 | 2 | 3 | |
| Preoperative | 7 | 3 | 4 | |
| Postoperative | 2 | 0 | 2 |
aModerate-to-vigorous intensity exercise minutes in a typical week in the month before baseline.
bModerate intensity exercise minutes in a typical week in the month before baseline.
cVigorous intensity exercise minutes in a typical week in the month before baseline.
dProphylactic Cranial Irradiation.